Cargando…

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO

OBJECTIVES: To examine anti-KIR4.1 antibodies by 2 different assays in Japanese patients with multiple sclerosis (MS) or neuromyelitis optica (NMO). METHODS: One hundred sixty serum samples from 57 patients with MS, 40 patients with NMO/NMO spectrum disorder (NMOSD), and 50 healthy controls (all wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higuchi, Osamu, Nakane, Shunya, Sakai, Waka, Maeda, Yasuhiro, Niino, Masaaki, Takahashi, Toshiyuki, Fukazawa, Toshiyuki, Kikuchi, Seiji, Fujihara, Kazuo, Matsuo, Hidenori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959509/ https://www.ncbi.nlm.nih.gov/pubmed/27489866 http://dx.doi.org/10.1212/NXI.0000000000000263

Ejemplares similares

Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity
por: Imamura, Michie, et al.
Publicado: (2020)

An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis
por: Niino, Masaaki, et al.
Publicado: (2002)

Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients
por: Nakane, Shunya, et al.
Publicado: (2015)

Autoantibodies to Potassium Channel KIR4.1 in Multiple Sclerosis
por: Schneider, Raphael
Publicado: (2013)

Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
por: Fujihara, Kazuo, et al.
Publicado: (2014)

Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan
por: Hayashi, Toshiyuki, et al.
Publicado: (2022)

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
por: Zeka, Bleranda, et al.
Publicado: (2016)

Finding NMO
por: Daneman, Richard
Publicado: (2016)

Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis
por: Kikuchi, Hiromi, et al.
Publicado: (2013)

Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis
por: Sato, Kazunori, et al.
Publicado: (2018)

Therapy of NMO spectrum disorders
por: Biswas, Atanu, et al.
Publicado: (2015)

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)

Immunotherapy for ocular myasthenia gravis: an observational study in Japan
por: Narita, Tomoko, et al.
Publicado: (2023)

Neurodegeneration in MS and NMO: The Eye and the Blood
por: Petzold, Axel, et al.
Publicado: (2011)

Neuromyelitis optica (NMO) and autoimmune thyroiditis
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
por: Kitic, Maja, et al.
Publicado: (2013)

EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies
por: Lo, Jacky, et al.
Publicado: (2022)

Kir5.1 underlies long-lived subconductance levels in heteromeric Kir4.1/Kir5.1 channels from Xenopus tropicalis
por: Shang, Lijun, et al.
Publicado: (2009)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS
por: Brasko, C., et al.
Publicado: (2016)

Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCE(NMO) Study
por: Hümmert, Martin W., et al.
Publicado: (2022)

Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity
por: Schirmer, Lucas, et al.
Publicado: (2018)

Kir4.1 Dysfunction in the Pathophysiology of Depression: A Systematic Review
por: Della Vecchia, Stefania, et al.
Publicado: (2021)

Kir4.1 is coexpressed with stemness markers in activated astrocytes in the injured brain and a Kir4.1 inhibitor BaCl(2) negatively regulates neurosphere formation in culture
por: Kwon, Jae-Kyung, et al.
Publicado: (2021)

Biophysical and Molecular Mechanisms Underlying the Modulation of Heteromeric Kir4.1–Kir5.1 Channels by Co(2) and Ph
por: Yang, Zhenjiang, et al.
Publicado: (2000)

Non-equivalent role of TM2 gating hinges in heteromeric Kir4.1/Kir5.1 potassium channels
por: Shang, Lijun, et al.
Publicado: (2007)

Calcineurin inhibitors stimulate Kir4.1/Kir5.1 of the distal convoluted tubule to increase NaCl cotransporter
por: Zhang, Dan-Dan, et al.
Publicado: (2023)

Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study
por: Nakamura, Yuri, et al.
Publicado: (2016)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

The Neuroglial Potassium Cycle during Neurotransmission: Role of Kir4.1 Channels
por: Sibille, Jérémie, et al.
Publicado: (2015)

MeCP2 Deficiency Leads to Loss of Glial Kir4.1
por: Kahanovitch, Uri, et al.
Publicado: (2018)

Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes
por: Alex, Alpha, et al.
Publicado: (2020)

Role of Astrocytic Inwardly Rectifying Potassium (Kir) 4.1 Channels in Epileptogenesis
por: Kinboshi, Masato, et al.
Publicado: (2020)

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS
por: Zeka, Bleranda, et al.
Publicado: (2015)

Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions
por: Butt, Arthur M, et al.
Publicado: (2006)

The Effectiveness of the Stereotactic Burr Hole Technique for Deep Brain Stimulation
por: TOYODA, Keisuke, et al.
Publicado: (2015)

KIR4.1: K(+) Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis
por: Gu, Chen
Publicado: (2016)

Astrocytic Kir4.1 channels and gap junctions account for spontaneous epileptic seizure
por: Du, Mengmeng, et al.
Publicado: (2018)

Antiepileptic Drugs Elevate Astrocytic Kir4.1 Expression in the Rat Limbic Region
por: Mukai, Takahiro, et al.
Publicado: (2018)

Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain Diseases
por: Ohno, Yukihiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9oql5npddur7mq6bk7fhfrp5g5